Income (Loss) Per Share - Schedule of Effect of Shares No Longer Anti-Dilutive (Details) - shares	3 Months Ended	15 Months Ended
	Jun. 30, 2026	Jun. 30, 2026
Anti-dilutive securities not included in the calculation of diluted EPS (weighted average):
Total	5,630,139	4,443,516
Convertible debt [Member]
Anti-dilutive securities not included in the calculation of diluted EPS (weighted average):
Total	2,524,723
Warrants [Member]
Anti-dilutive securities not included in the calculation of diluted EPS (weighted average):
Total	709,040
Convertible series C preferred stock [Member]
Anti-dilutive securities not included in the calculation of diluted EPS (weighted average):
Total	112,738
Stock options [Member]
Anti-dilutive securities not included in the calculation of diluted EPS (weighted average):
Total	202
Common stock subscribed but unissued [Member]
Anti-dilutive securities not included in the calculation of diluted EPS (weighted average):
Total	44
Non-vested RSUs outstanding [Member]
Anti-dilutive securities not included in the calculation of diluted EPS (weighted average):
Total	2,283,392	4,443,516